Finance

Lists
Why is 300511 up 7.21%?
Dive Deeper
300511:SHE
Shanghai Xuerong Biotechnology Co Ltd
CNÂ¥4.31
+7.21%
(+0.29) 1D
Nov 4, 3:04:40 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300511...
Open
CNÂ¥4.37
High
CNÂ¥4.58
Low
CNÂ¥4.22
Mkt. cap
2.58B
Avg. vol.
16.90M
Volume
47.06M
P/E ratio
71.22
52-wk high
CNÂ¥8.50
52-wk low
CNÂ¥3.88
EPS
CNÂ¥0.06
Shares outstanding
640.85M
No. of employees
2K
Open
CNÂ¥4.37
High
CNÂ¥4.58
Low
CNÂ¥4.22
Mkt. cap
2.58B
Avg. vol.
16.90M
Volume
47.06M
P/E ratio
71.22
52-wk high
CNÂ¥8.50
52-wk low
CNÂ¥3.88
EPS
CNÂ¥0.06
Shares outstanding
640.85M
No. of employees
2K
News stories
From web sources and news partners
About Shanghai Xuerong Biotechnology Co Ltd
CEO-
Employees1.92K
Founded1995
Headquarters-
SectorFood
Industry-
Websitexuerong.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
662.68M
678.92M
477.38M
542.34M
Cost of goods sold
506.32M
450.58M
577.16M
440.18M
Cost of revenue
506.32M
450.58M
577.16M
440.18M
Research and development expenses
976.13K
776.37K
1.23M
1.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43.50M
34.05M
47.05M
37.73M
Operating expense
50.47M
39.79M
53.55M
37.82M
Total operating expenses
556.79M
490.37M
630.71M
478.00M
Operating income
105.89M
188.55M
-153.34M
64.34M
Other non operating income
-425.46K
-5.97M
5.90M
-12.33M
EBT including unusual items
94.64M
175.70M
-161.76M
-62.73M
EBT excluding unusual items
93.84M
173.35M
-165.94M
54.06M
Income tax expense
15.39K
48.31K
163.44K
18.13K
Effective tax rate
0.02%
0.03%
-0.10%
-0.03%
Other operating expenses
5.48M
5.15M
4.93M
-2.86M
Net income
92.14M
173.17M
-155.32M
-65.25M
Net profit margin
13.90%
25.51%
-32.54%
-12.03%
Earnings per share
-
-
-
-
Interest and investment income
380.11K
196.43K
1.10M
56.41K
Interest expense
-16.04M
-9.42M
-9.74M
-7.88M
Net interest expenses
-15.66M
-9.23M
-8.64M
-7.82M
Depreciation and amortization charges
-
-
-
-
EBITDA
190.05M
272.71M
-69.55M
148.49M
Gain or loss from assets sale
-16.31M
-
2.30M
-2.30M
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps